Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: An adipokine-mediated process?

Age-dependent changes in insulin action and body fat distribution are risk factors for the development of type 2 diabetes. To examine whether the accumulation of visceral fat (VF) could play a direct role in the pathophysiology of insulin resistance and type 2 diabetes, we monitored insulin action,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2002-10, Vol.51 (10), p.2951-2958
Hauptverfasser: GABRIELY, Ilan, XIAO HUI MA, XIAO MAN YANG, ATZMON, Gil, RAJALA, Michael W, BERG, Anders H, SCHERER, Phillip, ROSSETTI, Luciano, BARZILAI, Nir
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2958
container_issue 10
container_start_page 2951
container_title Diabetes (New York, N.Y.)
container_volume 51
creator GABRIELY, Ilan
XIAO HUI MA
XIAO MAN YANG
ATZMON, Gil
RAJALA, Michael W
BERG, Anders H
SCHERER, Phillip
ROSSETTI, Luciano
BARZILAI, Nir
description Age-dependent changes in insulin action and body fat distribution are risk factors for the development of type 2 diabetes. To examine whether the accumulation of visceral fat (VF) could play a direct role in the pathophysiology of insulin resistance and type 2 diabetes, we monitored insulin action, glucose tolerance, and the expression of adipo-derived peptides after surgical removal of VF in aging (20-month-old) F344/Brown Norway (FBN) and in Zucker Diabetic Fatty (ZDF) rats. As expected, peripheral and hepatic insulin action were markedly impaired in aging FBN rats, and extraction of VF (accounting for approximately 18% of their total body fat) was sufficient to restore peripheral and hepatic insulin action to the levels of young rats. When examined at the mechanistic level, removal of VF in ZDF rats prevented the progressive decrease in insulin action and delayed the onset of diabetes, but VF extraction did not alter plasma free fatty acid levels. However, the expression of tumor necrosis factor-alpha and leptin in subcutaneous (SC) adipose tissue were markedly decreased after VF removal (by approximately three- and twofold, respectively). Finally, extracted VF retained approximately 15-fold higher resistin mRNA compared with SC fat. Our data suggest that insulin resistance and the development of diabetes can be significantly reduced in aging rats by preventing the age-dependent accumulation of VF. This study documents a cause-and-effect relationship between VF and major components of the metabolic syndrome.
doi_str_mv 10.2337/diabetes.51.10.2951
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72125593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A92520036</galeid><sourcerecordid>A92520036</sourcerecordid><originalsourceid>FETCH-LOGICAL-g436t-28e75fc9d372c5666f909b1de0dc6802382bb90d0d91726388d12643f6eab31e3</originalsourceid><addsrcrecordid>eNp9kl1rFDEUhoModq3-AkEGweKFs-Zjk5l4I8tiW2GhIAreDZnkzJCaSbaTzGL_vRlcaStLORcJJ0_ec_KeIPSa4CVlrPporGohQVxyspxzkpMnaEEkkyWj1c-naIExoSWpZHWCXsR4jTEWOZ6jE0IZJytGFyh9gyHslStCV-xt1DDmfadSsRthDz7Fwvo4OeuLEaKNSXkNhfKm6N2kQ4R8nILLt-Z81lC99f2nYu0LZewu_LIeygFyqwlM1gwaYvz8Ej3rlIvw6rCeoh_nX75vLsvt1cXXzXpb9ismUklrqHinpWEV1VwI0UksW2IAGy1qTFlN21Zig40kFRWsrg2hYsU6AaplBNgpOvurmwvfTBBTM8xPdE55CFNsKkoo55Jl8O1_4HWYRp97aygRq4oQfg_qlYPG-i6kUelZsVlLyinGTGTowxGoBz8bGzx0Nqfv4-URPIeBwepj_PsHfEYS_E69mmJs6ovtI50cUB2cgx6abPTm6gH-5mDB1OaBNbvRDmq8bf59lQy8OwAqauW6eeQ23nFMclFn9_8Aig3L1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216471153</pqid></control><display><type>article</type><title>Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: An adipokine-mediated process?</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>GABRIELY, Ilan ; XIAO HUI MA ; XIAO MAN YANG ; ATZMON, Gil ; RAJALA, Michael W ; BERG, Anders H ; SCHERER, Phillip ; ROSSETTI, Luciano ; BARZILAI, Nir</creator><creatorcontrib>GABRIELY, Ilan ; XIAO HUI MA ; XIAO MAN YANG ; ATZMON, Gil ; RAJALA, Michael W ; BERG, Anders H ; SCHERER, Phillip ; ROSSETTI, Luciano ; BARZILAI, Nir</creatorcontrib><description>Age-dependent changes in insulin action and body fat distribution are risk factors for the development of type 2 diabetes. To examine whether the accumulation of visceral fat (VF) could play a direct role in the pathophysiology of insulin resistance and type 2 diabetes, we monitored insulin action, glucose tolerance, and the expression of adipo-derived peptides after surgical removal of VF in aging (20-month-old) F344/Brown Norway (FBN) and in Zucker Diabetic Fatty (ZDF) rats. As expected, peripheral and hepatic insulin action were markedly impaired in aging FBN rats, and extraction of VF (accounting for approximately 18% of their total body fat) was sufficient to restore peripheral and hepatic insulin action to the levels of young rats. When examined at the mechanistic level, removal of VF in ZDF rats prevented the progressive decrease in insulin action and delayed the onset of diabetes, but VF extraction did not alter plasma free fatty acid levels. However, the expression of tumor necrosis factor-alpha and leptin in subcutaneous (SC) adipose tissue were markedly decreased after VF removal (by approximately three- and twofold, respectively). Finally, extracted VF retained approximately 15-fold higher resistin mRNA compared with SC fat. Our data suggest that insulin resistance and the development of diabetes can be significantly reduced in aging rats by preventing the age-dependent accumulation of VF. This study documents a cause-and-effect relationship between VF and major components of the metabolic syndrome.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/diabetes.51.10.2951</identifier><identifier>PMID: 12351432</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Abdomen ; Adipose tissue ; Adipose Tissue - metabolism ; Adipose Tissue - surgery ; Adipose tissues ; Aging ; Aging (Biology) ; Aging - metabolism ; Animals ; Biological and medical sciences ; Body Composition ; Body fat ; Cardiovascular disease ; Diabetes ; Diabetes Mellitus, Type 2 - metabolism ; Diabetes Mellitus, Type 2 - prevention &amp; control ; Diabetes research ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Fatty Acids, Nonesterified - blood ; Gene Expression - physiology ; Glucose - metabolism ; Glucose intolerance ; Health aspects ; Hormones, Ectopic - genetics ; Insulin resistance ; Insulin Resistance - physiology ; Japanese Americans ; Leptin - genetics ; Leptin - metabolism ; Medical sciences ; Metabolism ; Nerve Growth Factor ; Obesity ; Obesity - metabolism ; Obesity - surgery ; Peptides ; Physiological aspects ; Proteins ; Rats ; Rats, Inbred BN ; Rats, Inbred F344 ; Rats, Zucker ; Resistin ; Statistics ; Tumor Necrosis Factor-alpha - metabolism ; Tumor necrosis factor-TNF</subject><ispartof>Diabetes (New York, N.Y.), 2002-10, Vol.51 (10), p.2951-2958</ispartof><rights>2003 INIST-CNRS</rights><rights>COPYRIGHT 2002 American Diabetes Association</rights><rights>Copyright American Diabetes Association Oct 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13956864$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12351432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GABRIELY, Ilan</creatorcontrib><creatorcontrib>XIAO HUI MA</creatorcontrib><creatorcontrib>XIAO MAN YANG</creatorcontrib><creatorcontrib>ATZMON, Gil</creatorcontrib><creatorcontrib>RAJALA, Michael W</creatorcontrib><creatorcontrib>BERG, Anders H</creatorcontrib><creatorcontrib>SCHERER, Phillip</creatorcontrib><creatorcontrib>ROSSETTI, Luciano</creatorcontrib><creatorcontrib>BARZILAI, Nir</creatorcontrib><title>Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: An adipokine-mediated process?</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Age-dependent changes in insulin action and body fat distribution are risk factors for the development of type 2 diabetes. To examine whether the accumulation of visceral fat (VF) could play a direct role in the pathophysiology of insulin resistance and type 2 diabetes, we monitored insulin action, glucose tolerance, and the expression of adipo-derived peptides after surgical removal of VF in aging (20-month-old) F344/Brown Norway (FBN) and in Zucker Diabetic Fatty (ZDF) rats. As expected, peripheral and hepatic insulin action were markedly impaired in aging FBN rats, and extraction of VF (accounting for approximately 18% of their total body fat) was sufficient to restore peripheral and hepatic insulin action to the levels of young rats. When examined at the mechanistic level, removal of VF in ZDF rats prevented the progressive decrease in insulin action and delayed the onset of diabetes, but VF extraction did not alter plasma free fatty acid levels. However, the expression of tumor necrosis factor-alpha and leptin in subcutaneous (SC) adipose tissue were markedly decreased after VF removal (by approximately three- and twofold, respectively). Finally, extracted VF retained approximately 15-fold higher resistin mRNA compared with SC fat. Our data suggest that insulin resistance and the development of diabetes can be significantly reduced in aging rats by preventing the age-dependent accumulation of VF. This study documents a cause-and-effect relationship between VF and major components of the metabolic syndrome.</description><subject>Abdomen</subject><subject>Adipose tissue</subject><subject>Adipose Tissue - metabolism</subject><subject>Adipose Tissue - surgery</subject><subject>Adipose tissues</subject><subject>Aging</subject><subject>Aging (Biology)</subject><subject>Aging - metabolism</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Composition</subject><subject>Body fat</subject><subject>Cardiovascular disease</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diabetes Mellitus, Type 2 - prevention &amp; control</subject><subject>Diabetes research</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Fatty Acids, Nonesterified - blood</subject><subject>Gene Expression - physiology</subject><subject>Glucose - metabolism</subject><subject>Glucose intolerance</subject><subject>Health aspects</subject><subject>Hormones, Ectopic - genetics</subject><subject>Insulin resistance</subject><subject>Insulin Resistance - physiology</subject><subject>Japanese Americans</subject><subject>Leptin - genetics</subject><subject>Leptin - metabolism</subject><subject>Medical sciences</subject><subject>Metabolism</subject><subject>Nerve Growth Factor</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>Obesity - surgery</subject><subject>Peptides</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Inbred BN</subject><subject>Rats, Inbred F344</subject><subject>Rats, Zucker</subject><subject>Resistin</subject><subject>Statistics</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Tumor necrosis factor-TNF</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kl1rFDEUhoModq3-AkEGweKFs-Zjk5l4I8tiW2GhIAreDZnkzJCaSbaTzGL_vRlcaStLORcJJ0_ec_KeIPSa4CVlrPporGohQVxyspxzkpMnaEEkkyWj1c-naIExoSWpZHWCXsR4jTEWOZ6jE0IZJytGFyh9gyHslStCV-xt1DDmfadSsRthDz7Fwvo4OeuLEaKNSXkNhfKm6N2kQ4R8nILLt-Z81lC99f2nYu0LZewu_LIeygFyqwlM1gwaYvz8Ej3rlIvw6rCeoh_nX75vLsvt1cXXzXpb9ismUklrqHinpWEV1VwI0UksW2IAGy1qTFlN21Zig40kFRWsrg2hYsU6AaplBNgpOvurmwvfTBBTM8xPdE55CFNsKkoo55Jl8O1_4HWYRp97aygRq4oQfg_qlYPG-i6kUelZsVlLyinGTGTowxGoBz8bGzx0Nqfv4-URPIeBwepj_PsHfEYS_E69mmJs6ovtI50cUB2cgx6abPTm6gH-5mDB1OaBNbvRDmq8bf59lQy8OwAqauW6eeQ23nFMclFn9_8Aig3L1A</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>GABRIELY, Ilan</creator><creator>XIAO HUI MA</creator><creator>XIAO MAN YANG</creator><creator>ATZMON, Gil</creator><creator>RAJALA, Michael W</creator><creator>BERG, Anders H</creator><creator>SCHERER, Phillip</creator><creator>ROSSETTI, Luciano</creator><creator>BARZILAI, Nir</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20021001</creationdate><title>Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: An adipokine-mediated process?</title><author>GABRIELY, Ilan ; XIAO HUI MA ; XIAO MAN YANG ; ATZMON, Gil ; RAJALA, Michael W ; BERG, Anders H ; SCHERER, Phillip ; ROSSETTI, Luciano ; BARZILAI, Nir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g436t-28e75fc9d372c5666f909b1de0dc6802382bb90d0d91726388d12643f6eab31e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Abdomen</topic><topic>Adipose tissue</topic><topic>Adipose Tissue - metabolism</topic><topic>Adipose Tissue - surgery</topic><topic>Adipose tissues</topic><topic>Aging</topic><topic>Aging (Biology)</topic><topic>Aging - metabolism</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Composition</topic><topic>Body fat</topic><topic>Cardiovascular disease</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diabetes Mellitus, Type 2 - prevention &amp; control</topic><topic>Diabetes research</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Fatty Acids, Nonesterified - blood</topic><topic>Gene Expression - physiology</topic><topic>Glucose - metabolism</topic><topic>Glucose intolerance</topic><topic>Health aspects</topic><topic>Hormones, Ectopic - genetics</topic><topic>Insulin resistance</topic><topic>Insulin Resistance - physiology</topic><topic>Japanese Americans</topic><topic>Leptin - genetics</topic><topic>Leptin - metabolism</topic><topic>Medical sciences</topic><topic>Metabolism</topic><topic>Nerve Growth Factor</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>Obesity - surgery</topic><topic>Peptides</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Inbred BN</topic><topic>Rats, Inbred F344</topic><topic>Rats, Zucker</topic><topic>Resistin</topic><topic>Statistics</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GABRIELY, Ilan</creatorcontrib><creatorcontrib>XIAO HUI MA</creatorcontrib><creatorcontrib>XIAO MAN YANG</creatorcontrib><creatorcontrib>ATZMON, Gil</creatorcontrib><creatorcontrib>RAJALA, Michael W</creatorcontrib><creatorcontrib>BERG, Anders H</creatorcontrib><creatorcontrib>SCHERER, Phillip</creatorcontrib><creatorcontrib>ROSSETTI, Luciano</creatorcontrib><creatorcontrib>BARZILAI, Nir</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GABRIELY, Ilan</au><au>XIAO HUI MA</au><au>XIAO MAN YANG</au><au>ATZMON, Gil</au><au>RAJALA, Michael W</au><au>BERG, Anders H</au><au>SCHERER, Phillip</au><au>ROSSETTI, Luciano</au><au>BARZILAI, Nir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: An adipokine-mediated process?</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2002-10-01</date><risdate>2002</risdate><volume>51</volume><issue>10</issue><spage>2951</spage><epage>2958</epage><pages>2951-2958</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Age-dependent changes in insulin action and body fat distribution are risk factors for the development of type 2 diabetes. To examine whether the accumulation of visceral fat (VF) could play a direct role in the pathophysiology of insulin resistance and type 2 diabetes, we monitored insulin action, glucose tolerance, and the expression of adipo-derived peptides after surgical removal of VF in aging (20-month-old) F344/Brown Norway (FBN) and in Zucker Diabetic Fatty (ZDF) rats. As expected, peripheral and hepatic insulin action were markedly impaired in aging FBN rats, and extraction of VF (accounting for approximately 18% of their total body fat) was sufficient to restore peripheral and hepatic insulin action to the levels of young rats. When examined at the mechanistic level, removal of VF in ZDF rats prevented the progressive decrease in insulin action and delayed the onset of diabetes, but VF extraction did not alter plasma free fatty acid levels. However, the expression of tumor necrosis factor-alpha and leptin in subcutaneous (SC) adipose tissue were markedly decreased after VF removal (by approximately three- and twofold, respectively). Finally, extracted VF retained approximately 15-fold higher resistin mRNA compared with SC fat. Our data suggest that insulin resistance and the development of diabetes can be significantly reduced in aging rats by preventing the age-dependent accumulation of VF. This study documents a cause-and-effect relationship between VF and major components of the metabolic syndrome.</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>12351432</pmid><doi>10.2337/diabetes.51.10.2951</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2002-10, Vol.51 (10), p.2951-2958
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_miscellaneous_72125593
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Abdomen
Adipose tissue
Adipose Tissue - metabolism
Adipose Tissue - surgery
Adipose tissues
Aging
Aging (Biology)
Aging - metabolism
Animals
Biological and medical sciences
Body Composition
Body fat
Cardiovascular disease
Diabetes
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - prevention & control
Diabetes research
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Fatty Acids, Nonesterified - blood
Gene Expression - physiology
Glucose - metabolism
Glucose intolerance
Health aspects
Hormones, Ectopic - genetics
Insulin resistance
Insulin Resistance - physiology
Japanese Americans
Leptin - genetics
Leptin - metabolism
Medical sciences
Metabolism
Nerve Growth Factor
Obesity
Obesity - metabolism
Obesity - surgery
Peptides
Physiological aspects
Proteins
Rats
Rats, Inbred BN
Rats, Inbred F344
Rats, Zucker
Resistin
Statistics
Tumor Necrosis Factor-alpha - metabolism
Tumor necrosis factor-TNF
title Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: An adipokine-mediated process?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T13%3A22%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Removal%20of%20visceral%20fat%20prevents%20insulin%20resistance%20and%20glucose%20intolerance%20of%20aging:%20An%20adipokine-mediated%20process?&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=GABRIELY,%20Ilan&rft.date=2002-10-01&rft.volume=51&rft.issue=10&rft.spage=2951&rft.epage=2958&rft.pages=2951-2958&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/diabetes.51.10.2951&rft_dat=%3Cgale_proqu%3EA92520036%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216471153&rft_id=info:pmid/12351432&rft_galeid=A92520036&rfr_iscdi=true